These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9210612

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
    Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH.
    J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758
    [Abstract] [Full Text] [Related]

  • 7. Autoantibodies to a miRNA-binding protein Argonaute2 (Su antigen) in patients with hepatitis C virus infection.
    Vázquez-Del Mercado M, Sánchez-Orozco LV, Pauley BA, Chan JY, Chan EK, Panduro A, Maldonado González M, Jiménez-Luévanos MA, Martín-Márquez BT, Palafox-Sánchez CA, Dávalos-Rodríguez IP, Salazar-Páramo M, González-López L, Gámez-Nava JI, Satoh M.
    Clin Exp Rheumatol; 2010 Oct; 28(6):842-8. PubMed ID: 21122261
    [Abstract] [Full Text] [Related]

  • 8. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
    Strassburg CP, Alex B, Zindy F, Gerken G, Lüttig B, Meyer zum Büschenfelde KH, Bréchot C, Manns MP.
    J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GOR-antibodies in patients with chronic liver disease and hepatocellular carcinoma.
    Rehermann B, Schneider A, Michel G, Braun HB, Manns MP.
    Z Gastroenterol; 1994 Jul; 32(7):396-8. PubMed ID: 7975776
    [Abstract] [Full Text] [Related]

  • 12. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
    Khin LW, Teo CJ, Guan R.
    Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Oct; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.
    Zhang JY, Zhu W, Imai H, Kiyosawa K, Chan EK, Tan EM.
    Clin Exp Immunol; 2001 Jul; 125(1):3-9. PubMed ID: 11472419
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Features and outcome after liver resection for non-B non-C hepatocellular carcinoma.
    Kaneda K, Kubo S, Tanaka H, Takemura S, Ohba K, Uenishi T, Kodai S, Shinkawa H, Urata Y, Sakae M, Yamamoto T, Suehiro S.
    Hepatogastroenterology; 2012 Sep; 59(118):1889-92. PubMed ID: 22819910
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.